A Four-Phenotype Model for Risk Stratification in Heart Failure with Preserved and Mildly Reduced Ejection Fraction:

Flavia-Mihaela Stoiculescu1,2, Diana-Ruxandra Hădăreanu2,3, Călin-Dinu Hădăreanu1,4

  • 1Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.

Biomedicines
|January 28, 2026
PubMed

Insights

Sex and diabetes significantly impact heart failure with mildly reduced and preserved ejection fraction (HFmrEF/HFpEF) risk. Diabetic men face the highest risk of rehospitalization, while women without diabetes have the best prognosis.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Clinical Risk Stratification

Background:

  • Sex and diabetes are key risk factors in heart failure with mildly reduced and preserved ejection fraction (HFmrEF/HFpEF).
  • The combined impact of sex and diabetes on HFmrEF/HFpEF outcomes remains under-evaluated.
  • Understanding these interactions is crucial for personalized patient management.

Purpose of the Study:

  • To investigate the influence of sex-diabetes phenotypes on clinical characteristics.
  • To assess the risk of heart failure rehospitalization based on these phenotypes.
  • To identify distinct risk profiles within the HFmrEF/HFpEF population.

Main Methods:

  • Retrospective analysis of 1018 HFmrEF/HFpEF patients (2019-2023).
  • Classification into four sex-diabetes phenotypes for group comparison.
  • Primary endpoint: heart failure rehospitalization, analyzed using univariate and adjusted models.

Main Results:

  • Phenotypes differed in age, renal function, cardiac structure, glycemia, and comorbidities.
  • Diabetic men exhibited greater structural remodeling and higher comorbidity burden.
  • Male sex and diabetes were independent predictors of rehospitalization (HR 1.28 for both).
  • Event-free survival showed a gradient: women without diabetes (best) to diabetic men (worst).

Conclusions:

  • Sex and diabetes interact to create unique risk profiles in HFmrEF/HFpEF.
  • Women without diabetes represent a low-risk group.
  • Diabetic men are at the highest risk for recurrent heart failure decompensation.
  • Sex-diabetes phenotyping can enhance risk stratification and personalize HFmrEF/HFpEF management.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
872
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
847
Role of Reduced Coenzymes NADH and FADH₂01:29

Role of Reduced Coenzymes NADH and FADH₂

The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
16.5K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
314
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
948